InsiderTrades

Form 4 for GALT GALECTIN THERAPEUTICS INC

Accepted 2023-09-27 00:00:00 ET · period of report 2023-09-26 · accession 0001133416-23-000075 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-09-27 2023-09-26 GALT Uihlein Richard E Dir, 10% M - OptEx $4.49 +2.24M 9.64M +30% +$10.03M
DM 2023-09-27 2023-09-26 GALT Uihlein Richard E Dir, 10% M - OptEx $0.00 -2.24M 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-09-26 M A 200,000 $3.00 9,835,495 D — —
2 Common Common Stock 2023-09-26 M A 200,000 $3.26 10,035,495 D — —
3 Common Common Stock 2023-09-26 M A 200,000 $3.00 10,235,495 D — —
4 Common Common Stock 2023-09-26 M A 1,466,204 $5.00 9,466,495 D — —
5 Common Common Stock 2023-09-26 M A 170,000 $5.00 9,635,495 D — —
6 Derivative Common Stock Purchase Warrant (right to buy) 2023-09-26 M D 1,466,204 $0.00 0 D $5.00 · 2017-06-22 to 2023-12-23 1,466,204 Common Stock
7 Derivative Common Stock Purchase Warrant (right to buy) 2023-09-26 M D 170,000 $0.00 330,000 D $5.00 · 2022-07-25 to 2029-07-31 170,000 Common Stock
8 Derivative Common Stock Purchase Warrant (right to buy) 2023-09-26 M D 200,000 $0.00 0 D $3.00 · 2023-06-30 to 2029-07-31 200,000 Common Stock
9 Derivative Common Stock Purchase Warrant (right to buy) 2023-09-26 M D 200,000 $0.00 0 D $3.26 · 2023-03-31 to 2029-07-31 200,000 Common Stock
10 Derivative Common Stock Purchase Warrant (right to buy) 2023-09-26 M D 200,000 $0.00 0 D $3.00 · 2022-12-19 to 2029-07-31 200,000 Common Stock